Atabak Mokari
2020 - BELLICUM PHARMACEUTICALS
In 2020, Atabak Mokari earned a total compensation of $1.7M as Former Chief Financial Officer at BELLICUM PHARMACEUTICALS, a 49% increase compared to previous year.
Compensation breakdown
| Option Awards | $542,889 |
|---|---|
| Salary | $408,373 |
| Stock Awards | $163,764 |
| Other | $536,708 |
| Total | $1,651,734 |
Mokari received $542.9K in option awards, accounting for 33% of the total pay in 2020.
Mokari also received $408.4K in salary, $163.8K in stock awards and $536.7K in other compensation.
Rankings
In 2020, Atabak Mokari's compensation ranked 6,408th out of 13,090 executives tracked by ExecPay. In other words, Mokari earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,408 out of 13,090 | 51st |
Division Manufacturing | 2,645 out of 5,621 | 53rd |
Major group Chemicals And Allied Products | 1,067 out of 2,254 | 53rd |
Industry group Drugs | 922 out of 1,954 | 53rd |
Industry Pharmaceutical Preparations | 690 out of 1,459 | 53rd |
Source: SEC filing on April 29, 2021.
Mokari's colleagues
We found two more compensation records of executives who worked with Atabak Mokari at BELLICUM PHARMACEUTICALS in 2020.